VETAX
Price
$52.15
Change
-$0.41 (-0.78%)
Updated
Sep 20 closing price
VMVAX
Price
$86.17
Change
-$0.37 (-0.43%)
Updated
Sep 20 closing price
Ad is loading...

VETAX vs VMVAX

Header iconVETAX vs VMVAX Comparison
Open Charts VETAX vs VMVAXBanner chart's image
Victory Sycamore Established Value A
Price$52.15
Change-$0.41 (-0.78%)
VolumeN/A
CapitalizationN/A
Vanguard Mid-Cap Value Index Admiral
Price$86.17
Change-$0.37 (-0.43%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
VETAX vs VMVAX Comparison Chart
Loading...
VS
VETAX vs. VMVAX commentary
Sep 22, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is VETAX is a Buy and VMVAX is a StrongBuy.

FUNDAMENTALS
Fundamentals
VMVAX has more cash in the bank: 30.5B vs. VETAX (19.3B). VMVAX pays higher dividends than VETAX: VMVAX (2.14) vs VETAX (1.05). VETAX was incepted earlier than VMVAX: VETAX (24 years) vs VMVAX (13 years). VETAX is a more actively managed with annual turnover of: 28.00 vs. VMVAX (22.00). VETAX has a lower initial minimum investment than VMVAX: VETAX (2500) vs VMVAX (3000). VMVAX annual gain was more profitable for investors over the last year : 25.35 vs. VETAX (19.46). VMVAX return over 5 years is better than : 48.82 vs. VETAX (39.22).
VETAXVMVAXVETAX / VMVAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence24 years13 years-
Gain YTD13.93714.94693%
Front LoadN/AN/A-
Min. Initial Investment2500300083%
Min. Initial Investment IRAN/AN/A-
Net Assets19.3B30.5B63%
Annual Yield % from dividends1.052.1449%
Returns for 1 year19.4625.3577%
Returns for 3 years11.7920.7157%
Returns for 5 years39.2248.8280%
Returns for 10 years60.14100.8860%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AUUD0.790.01
+0.67%
Auddia
CTLT60.00-0.11
-0.18%
CATALENT
JAMF18.49-0.09
-0.48%
Jamf Holding Corp
ARCT20.61-0.41
-1.95%
Arcturus Therapeutics Holdings
ANVS8.47-0.17
-1.97%
Annovis Bio